 | • レポートコード：TPM-B04550 • 出版社/出版日：Transparency Market Research / 2017年10月 • レポート形態：英文、PDF、153ページ • 納品方法：Eメール • 産業分類：製薬・医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、医薬品連続製造の世界市場について調べ、医薬品連続製造の世界規模、市場動向、市場環境、用途別分析、エンドユーザー別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・医薬品連続製造の世界市場動向 ・医薬品連続製造の世界市場環境 ・医薬品連続製造の世界市場規模 ・医薬品連続製造の世界市場規模：用途別 ・医薬品連続製造の世界市場規模：エンドユーザー別 ・医薬品連続製造の世界市場：地域別市場規模・分析 ・医薬品連続製造の北米市場規模・予測 ・医薬品連続製造のアメリカ市場規模・予測 ・医薬品連続製造の中南米市場規模・予測 ・医薬品連続製造のヨーロッパ市場規模・予測 ・医薬品連続製造のアジア市場規模・予測 ・医薬品連続製造の中東市場規模・予測 ・医薬品連続製造のアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Global Pharmaceutical Continuous Manufacturing Technology Market: Overview
This report on pharmaceutical continuous manufacturing technology market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global pharmaceutical continuous manufacturing technology market with respect to the leading market segments based on major products segment, end users, and geographies.
The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the pharmaceutical continuous manufacturing technology market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global pharmaceutical continuous manufacturing technology market.
Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.
Global Pharmaceutical Continuous Manufacturing Technology Market: Segmentation
Based on the application type, the pharmaceutical continuous manufacturing technology market has been segmented into: active pharmaceutical ingredient, biologics, dry powders & others. In term of end-users products divided into pharmaceutical companies, contract manufacturing organizations and others. Each of the market segments have been extensively analyzed based on the market related factors such as increasing awareness worldwide, technological advancement, and growing number of user in various geographies.
Geographically, pharmaceutical continuous manufacturing technology market has been segmented into five major regions: North America, Europe, Asia, Latin America, and Rest of World. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions.
Global Pharmaceutical Continuous Manufacturing Technology Market: Competitive Analysis
A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter’s five forces analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global pharmaceutical continuous manufacturing technology market.
The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global pharmaceutical continuous manufacturing technology market. The report also profiles key players operating in the pharmaceutical continuous manufacturing technology market which are Siemens AG, GEA group, Continuus Pharmaceutical, S K Biotek ltd, Korsch AG, Scott Equipment Company, Corning Life Sciences, Chemtrix, Ehrfeld etc.
The global pharmaceutical continuous manufacturing technology market is segmented as follows:
Global Pharmaceutical continuous manufacturing technology Market, by Application Type
Active Pharmaceutical ingredient
Biologics
Dry Powders
Others
Global Pharmaceutical continuous manufacturing technology Market, by End-users
Pharmaceutical Companies
Contract Manufacturing Organizations
Others
Global Pharmaceutical continuous manufacturing technology Market, by Geography
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of the Europe
Asia Pacific
China
Japan
India
Australia & New Zealand
Rest of Asia
Latin America (LATAM)
Brazil
Mexico
Rest of LATAM
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions
2.2. Acronyms Used
2.3. Research Methodology
3. Executive Summary
3.1. Global Pharmaceutical Continuous Manufacturing Technology Market Snapshot
4. Market Overview
4.1. Product Overview
4.2. Market Opportunity Map
4.3. Key Industry Events
4.4. Global Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, 2015–2025
4.5. Global Pharmaceutical Continuous Manufacturing Technology Market Outlook
4.6. Porter’s Five Forces Analysis
5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.2.1. Increased inefficiency in the manufacturing process
5.2.2. Safer production
5.2.3. Advantages over the batch manufacturing
5.2.4. Increased FDA initiatives
5.3. Restraints
5.3.1. Regulatory challenges
5.3.2. Difficulties in adoption
5.4. Opportunities
5.4.1. Improving Pharma Infrastructure
5.5. Global API Manufacturing Technology Suppliers Market Share Analysis, by Company, 2016 (estimated)
6. Global Pharmaceutical Continuous Manufacturing Technology Market, by Application
6.1. Introduction
6.2. Key Findings
6.3. Global Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application
6.4. Global Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Application
6.5. Global Pharmaceutical API Continuous Manufacturing Technology Forecast, by End-user
6.6. Global Pharmaceutical Continuous Manufacturing Technology Market Analysis, by Application
6.7. Global Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Application
6.8. Key Trends
7. Global Pharmaceutical Continuous Manufacturing Technology Market Analysis, by End-user
7.1. Introduction
7.2. Key Findings
7.3. Global Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user
7.4. Global Pharmaceutical Continuous Manufacturing Technology Market Forecast, by End-user
7.5. Global Pharmaceutical Continuous Manufacturing Technology Market Analysis, by End-user
7.6. Global Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by End-user
7.7. Key Trends
8. Global Pharmaceutical Continuous Manufacturing Technology Market Analysis, by Region
8.1. Global Market Scenario, by Country
8.2. Global Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Region
8.3. Global Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Region, 2015–2025
8.4. Global Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Region
9. North America Pharmaceutical Continuous Manufacturing Technology Market Analysis
9.1. Key Findings
9.2. North America Pharmaceutical Continuous Manufacturing Technology Market Overview
9.3. North America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Country
9.4. North America Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Country
9.5. North America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application
9.6. North America Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Application
9.7. North America Pharmaceutical API Continuous Manufacturing Technology Forecast, by End-user
9.8. North America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user
9.9. North America Pharmaceutical Continuous Manufacturing Technology Market Forecast, by End-user
9.10. North America Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis
9.11. Key Trends
10. Europe Pharmaceutical Continuous Manufacturing Technology Market Analysis
10.1. Key Findings
10.2. Europe Pharmaceutical Continuous Manufacturing Technology Market Overview
10.3. Europe Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Country
10.4. Europe Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Country
10.5. Europe Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application
10.6. Europe Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Application
10.7. Europe Pharmaceutical API Continuous Manufacturing Technology Forecast, by End-user
10.8. Europe Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user
10.9. Europe Pharmaceutical Continuous Manufacturing Technology Market Forecast, by End-user
10.10. Europe Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis
10.11. Key Trends
11. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Analysis
11.1. Key Findings
11.2. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Overview
11.3. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Country
11.4. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Country
11.5. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application
11.6. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Application
11.7. Asia Pacific Pharmaceutical API Continuous Manufacturing Technology Forecast, by End-user
11.8. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user
11.9. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Forecast, by End-user
11.10. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis
11.11. Key Trends
12. Latin America Pharmaceutical Continuous Manufacturing Technology Market Analysis
12.1. Key Findings
12.2. Latin America Pharmaceutical Continuous Manufacturing Technology Market Overview
12.3. Latin America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Country
12.4. Latin America Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Country
12.5. Latin America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application
12.6. Latin America Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Application
12.7. Latin America Pharmaceutical API Continuous Manufacturing Technology Forecast, by End-user
12.8. Latin America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user
12.9. Latin America Pharmaceutical Continuous Manufacturing Technology Market Forecast, by End-user
12.10. Latin America Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis
13. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Analysis
13.1. Key Findings
13.2. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Overview
13.3. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Country
13.4. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Country
13.5. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application
13.6. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Application
13.7. Middle East & Africa Pharmaceutical API Continuous Manufacturing Technology Forecast, by End-user
13.8. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user
13.9. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Forecast, by End-user
13.10. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis
14. Competition Landscape
14.1. Competition Matrix
14.2. Company Profiles
14.2.1. Siemens AG
14.2.1.1. Company Details
14.2.1.2. Business Overview
14.2.1.3. Financial Overview
14.2.1.4. Strategic Overview
14.2.1.5. SWOT Analysis
14.2.2. GEA Group
14.2.2.1. Company Details
14.2.2.2. Business Overview
14.2.2.3. Financial Overview
14.2.2.4. Strategic Overview
14.2.2.5. SWOT Analysis
14.2.3. SK biotek Co., Ltd.
14.2.3.1. Company Details
14.2.3.2. Business Overview
14.2.3.3. Financial Overview
14.2.3.4. Strategic Overview
14.2.3.5. SWOT Analysis
14.2.4. CONTINUUS Pharmaceuticals
14.2.4.1. Company Details
14.2.4.2. Business Overview
14.2.4.3. Financial Overview
14.2.4.4. Strategic Overview
14.2.4.5. SWOT Analysis
14.2.5. Gebrüder Lödige Maschinenbau GmbH
14.2.5.1. Company Details
14.2.5.2. Business Overview
14.2.5.3. Financial Overview
14.2.5.4. Strategic Overview
14.2.5.5. SWOT Analysis
14.2.6. Glatt GmbH
14.2.6.1. Company Details
14.2.6.2. Business Overview
14.2.6.3. Financial Overview
14.2.6.4. Strategic Overview
14.2.6.5. SWOT Analysis
14.2.7. KORSCH AG
14.2.7.1. Company Details
14.2.7.2. Business Overview
14.2.7.3. Financial Overview
14.2.7.4. Strategic Overview
14.2.7.5. SWOT Analysis
14.2.8. Scott Equipment Company
14.2.8.1. Company Details
14.2.8.2. Business Overview
14.2.8.3. Financial Overview
14.2.8.4. Strategic Overview
14.2.8.5. SWOT Analysis
14.2.9. Thermo Fisher Scientific, Inc.
14.2.9.1. Company Details
14.2.9.2. Business Overview
14.2.9.3. Financial Overview
14.2.9.4. Strategic Overview
14.2.9.5. SWOT Analysis
14.2.10. L.B. Bohle Maschinen + Verfahren Gmbh
14.2.10.1. Company Details
14.2.10.2. Business Overview
14.2.10.3. Financial Overview
14.2.10.4. Strategic Overview
14.2.10.5. SWOT Analysis
14.2.11. Munson Machinery Company
14.2.11.1. Company Details
14.2.11.2. Business Overview
14.2.11.3. Financial Overview
14.2.11.4. Strategic Overview
14.2.11.5. SWOT Analysis
TABLE 1 Revenue Share by Application
TABLE 2 Revenue Share by End-user
TABLE 3 Global Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Application, 2015–2025
TABLE 4 Global Pharmaceutical API Continuous Manufacturing Technology (US$ Mn) Forecast, by End-user, 2015–2025
TABLE 5 Global Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
TABLE 6 Global Pharmaceutical Continuous Manufacturing Technology Market Revenue (US$ Mn) Forecast, by Region, 2015–2025
TABLE 7 North America Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
TABLE 8 North America Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Application, 2015–2025
TABLE 9 North America Pharmaceutical API Continuous Manufacturing Technology (US$ Mn) Forecast, by End-user, 2015–2025
TABLE 10 North America Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
TABLE 11 Europe Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
TABLE 12 Europe Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Application, 2015–2025
TABLE 13 Europe Pharmaceutical API Continuous Manufacturing Technology (US$ Mn) Forecast, by End-user, 2015–2025
TABLE 14 Europe Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
TABLE 15 Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
TABLE 16 Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Application, 2015–2025
TABLE 17 Asia Pacific Pharmaceutical API Continuous Manufacturing Technology (US$ Mn) Forecast, by End-user, 2015–2025
TABLE 18 Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
TABLE 19 Latin America Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
TABLE 20 Latin America Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Application, 2015–2025
TABLE 21 Latin America Pharmaceutical API Continuous Manufacturing Technology Forecast, by End-user, 2015–2025
TABLE 22 Latin America Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
TABLE 23 Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
TABLE 24 Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Application, 2015–2025
TABLE 25 Middle East & Africa Pharmaceutical API Continuous Manufacturing Technology (US$ Mn) Forecast, by End-user, 2015–2025
TABLE 26 Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by End-user, 2015–2025